OmniAb, Inc. Common Stock
$4.35
$0.00 (+0.00%)
$4.27Day Range$4.45
Key Statistics
Market Cap
$632.45M
Shares Outstanding
145.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 1, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$4.38
Day High
$4.45
Day Low
$4.27
Volume
1.06M
VWAP
$4.36
Prev Close
$4.35
Transactions
--
Acc. Volume
--
About OmniAb, Inc. Common Stock
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHSIC 873189 employees5980 HORTON STREET, EMERYVILLE, CA, 94608510-250-7800IPO Nov 1, 2022US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001846253
- Composite FIGI
- BBG011J3QM39
- Share Class FIGI
- BBG011J3QM48
- Ticker Root
- OABI
- SIC Code
- 8731
About OmniAb, Inc. Common Stock (OABI) Stock
OmniAb, Inc. Common Stock (OABI) closed the 2026-09-16 session at $4.35, up 0.00% versus the previous close (+0.00). The stock opened at $4.38 and traded between $4.27 and $4.45 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $4.36.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
OmniAb, Inc. Common Stock has a market capitalization of $632.4 million. The company operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry classification. OABI is listed on the XNAS exchange. The company employs approximately 89 people. OmniAb, Inc. Common Stock is headquartered in EMERYVILLE, CA. The recorded listing date is 2022-11-01.
On this page you can find market OABI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector.